Fonte: Pharmaceuticals. Unidade: IFSC
Assuntos: PLANEJAMENTO DE FÁRMACOS, TUBERCULOSE, RESISTÊNCIA MICROBIANA ÀS DROGAS
ABNT
SANTOS, Nathália L. B. et al. Design, synthesis, and in vitro evaluation of 4-(arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: exploring their potential against tuberculosis. Pharmaceuticals, v. 18, n. 6, p. 797-1-797-21 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/ph18060797. Acesso em: 08 out. 2025.APA
Santos, N. L. B., Gomes, L. S., Ribeiro, R. C. B., Carvalho, A. S. de, Lourenço, M. C. da S., Marins, L. M., et al. (2025). Design, synthesis, and in vitro evaluation of 4-(arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: exploring their potential against tuberculosis. Pharmaceuticals, 18( 6), 797-1-797-21 + supplementary materials. doi:10.3390/ph18060797NLM
Santos NLB, Gomes LS, Ribeiro RCB, Carvalho AS de, Lourenço MC da S, Marins LM, Valle SP, Döring TH, Andricopulo AD, Oliveira AS de, Ferreira VF, Silva F de C da, Forezi L da SM, Nascimento V. Design, synthesis, and in vitro evaluation of 4-(arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: exploring their potential against tuberculosis [Internet]. Pharmaceuticals. 2025 ; 18( 6): 797-1-797-21 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph18060797Vancouver
Santos NLB, Gomes LS, Ribeiro RCB, Carvalho AS de, Lourenço MC da S, Marins LM, Valle SP, Döring TH, Andricopulo AD, Oliveira AS de, Ferreira VF, Silva F de C da, Forezi L da SM, Nascimento V. Design, synthesis, and in vitro evaluation of 4-(arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: exploring their potential against tuberculosis [Internet]. Pharmaceuticals. 2025 ; 18( 6): 797-1-797-21 + supplementary materials.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph18060797